| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $598.6K | 0.00% | 415.70K | New | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a MAIA trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 13, 2026 | Vitoc VladChief Executive Officer | Purchase at price 1.37 per share. | 73K | $100.01K |
| Sep 9, 2026 | Guerrero RamiroDirector | Purchase at price 1.32 per share. | 37.6K | $49.52K |
| Aug 27, 2026 | Guerrero RamiroDirector | Purchase at price 1.35 - 1.39 per share. | 133.8K | $184.10K |
| Aug 23, 2026 | Guerrero RamiroDirector | Purchase at price 1.33 per share. | 1.8K | $2.39K |
| Aug 19, 2026 | Guerrero RamiroDirector | Purchase at price 1.37 per share. | 11.9K | $16.30K |
| May 31, 2026 | Gryaznov Sergei M.Officer | Purchase at price 1.34 per share. | 2K | $2.69K |
| May 31, 2026 | Smith Stan VDirector | Purchase at price 1.34 per share. | 75K | $100.20K |
| May 31, 2026 | Vitoc VladChief Executive Officer | Purchase at price 1.39 per share. | 72.7K | $100.89K |
| Dec 21, 2025 | Chaouki Steven MDirector | Purchase at price 1.22 per share. | 40.8K | $50.00K |
| Dec 21, 2025 | Smith Stan VDirector | Purchase at price 1.22 per share. | 57.2K | $70.00K |
| Dec 21, 2025 | Louie Ngar YeeDirector | Purchase at price 1.22 per share. | 81.7K | $100.00K |
| Dec 4, 2025 | Smith Stan VDirector | Purchase at price 1.19 - 1.20 per share. | 13.7K | $16.44K |
| Nov 27, 2025 | Luput CristianDirector | Purchase at price 1.08 - 1.11 per share. | 38.1K | $41.85K |
| Nov 27, 2025 | Vitoc VladChief Executive Officer | Purchase at price 1.05 - 1.14 per share. | 72K | $79.85K |
| Nov 27, 2025 | Vitoc VladChief Executive Officer | Purchase at price 1.05 - 1.14 per share. | 72K | $79.85K |
| Nov 25, 2025 | Smith Stan VDirector | Purchase at price 1.04 per share. | 15K | $15.58K |
| Nov 24, 2025 | Luput CristianDirector | Purchase at price 0.98 per share. | 10K | $9.79K |
| Nov 24, 2025 | Smith Stan VDirector | Purchase at price 0.98 - 0.99 per share. | 25K | $24.60K |
| Nov 24, 2025 | Vitoc VladChief Executive Officer | Purchase at price 0.97 per share. | 10.5K | $10.14K |
| Nov 24, 2025 | Vitoc VladChief Executive Officer | Purchase at price 0.97 per share. | 10.5K | $10.14K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 57.5 | -6.2 | -38.1 | -5.0 | 4.5 | 3.6 | -13.2 | 4.8 | -9.9 | -2.1 | −24.5% | ||
| 2025 | -5.1 | 0.0 | -18.6 | 52.9 | -23.5 | 0.6 | -12.8 | -1.9 | 0.0 | -19.5 | -4.8 | 29.7 | −22.7% |
| 2024 | 28.2 | -12.7 | 67.9 | 33.2 | 62.1 | -28.0 | -5.6 | -5.9 | -7.6 | -1.1 | -20.5 | -10.4 | +69.2% |
| 2023 | 33.6 | -5.4 | -22.0 | -28.9 | 1.6 | -12.0 | 0.9 | -21.2 | 25.7 | -5.9 | -51.7 | 17.0 | −66.7% |
| 2022 | -30.5 | -18.1 | 10.6 | 1.4 | -5.1 | −39.5% |
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Buy / hold / sell counts